Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ON101 Efficacy for Lower-extremity Fracture Incisions
NCT07854470Completed
- Start
- Sep 2024
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Single-blind trial of Fespixon in wound healing (2 arms). Primary endpoints: Vancouver Scar Scale at Week 16 and Standardized photographs analyzed using CIELab color parameters and GLCM texture features at Week 16. Started Sep 2024; status: completed.
02
Drugs
Fespixon
03
Conditions
wound healing
Beyond the preview
Go deeper on NCT07854470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07854470.